NGAL and Acute Heart Failure (AHF)

By On 23. January 2012 · Leave a Comment · In BioPorto

According to an article in the European Journal of Heart Failure using pNGAL as well as a standard BNP test, in patients to be released from admission, gave the most precise result, about who were most likely to be readmitted, or to die after release.

This is most interesting, as it opens up another way to the hospitals for the NGAL test. And if your hospital is already running the patented NGAL AKI test, why not use the same equipment for your AHF test?

About Karl M. Bidstrup

Tidligere ejer af Medicoinvestor.com Strategien har gennem mange år været at profitere på etablerede aktier, og brænde det hele af på Bioporto... Sad but true. Kontakt mig på medicoinvestor(A)gmail.com hvis du har en million du ikke ved hvor du skal gemme, så skal jeg nok holde den for dig. 🙂

Related posts:

  1. NGAL as a marker of Acute Heart Failure (AHF) “Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with...
 

Leave a Reply

Your email address will not be published. Required fields are marked *

Set your Twitter account name in your settings to use the TwitterBar Section.